Production (Stage)
Xtant Medical Holdings, Inc.
XTNT
$0.7368
$0.01031.42%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 20.81% | 28.44% | 45.11% | 63.37% | 60.81% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 20.81% | 28.44% | 45.11% | 63.37% | 60.81% |
| Cost of Revenue | 31.13% | 36.88% | 39.91% | 48.34% | 40.09% |
| Gross Profit | 14.34% | 22.99% | 48.66% | 74.39% | 77.24% |
| SG&A Expenses | 5.24% | 21.18% | 50.97% | 77.48% | 78.21% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.61% | 27.48% | 47.75% | 67.19% | 63.11% |
| Operating Income | 37.42% | -18.87% | -73.34% | -106.45% | -85.42% |
| Income Before Tax | -260.11% | -1,468.27% | -3,462.28% | 43.53% | 60.14% |
| Income Tax Expenses | 105.72% | 111.02% | 132.98% | -2,798.33% | -2,836.67% |
| Earnings from Continuing Operations | -621.54% | -2,592.42% | -738.63% | 62.25% | 80.10% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -621.54% | -2,592.42% | -738.63% | 62.25% | 80.10% |
| EBIT | 37.42% | -18.87% | -73.34% | -106.45% | -85.42% |
| EBITDA | 61.06% | -12.41% | -76.96% | -109.86% | -66.28% |
| EPS Basic | -476.00% | -40,100.00% | -1,178.23% | 71.11% | 82.21% |
| Normalized Basic EPS | 27.82% | -13.89% | -46.14% | -52.37% | -42.26% |
| EPS Diluted | -427.06% | -3,768.75% | -1,556.38% | 70.31% | 81.22% |
| Normalized Diluted EPS | 26.74% | -15.84% | -49.02% | -50.28% | -40.15% |
| Average Basic Shares Outstanding | 13.16% | 16.36% | 15.70% | 23.66% | 24.99% |
| Average Diluted Shares Outstanding | 12.32% | 14.55% | 13.82% | 25.45% | 26.89% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |